ArticleBMC bioinformatics2022
Prediction of lung cancer using gene expression and deep learning with KL divergence gene selection.
Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Consolidated Evidence and New Frontiers of Liquid Biopsy in Lung Cancer: A Narrative Review.Cells · 2026Review
- Regulatory Potential of piRNAs TargetingGenes · 2026Article
- A hybrid feature extraction framework combining PCA and mutual information for gene expression based lung cancer classification.PloS one · 2026Article
- Pan-cancer gene set discovery via scRNA-seq for optimal deep learning based downstream tasks.Scientific reports · 2025Article
- Classification of lung cancer severity using gene expression data based on deep learning.BMC medical informatics and decision making · 2025Article
- Genetic feature selection algorithm as an efficient glioma grade classifier.Scientific reports · 2025Article
- Breast Cancer Detection Using Convolutional Neural Networks: A Deep Learning-Based Approach.Cureus · 2025Review
- Lung Cancer Biomarker Database (LCBD): a comprehensive and curated repository of lung cancer biomarkers.BMC cancer · 2025Article
- Margin weighted robust discriminant score for feature selection in imbalanced gene expression classification.PloS one · 2025Article
- High-precision lung cancer subtype diagnosis on imbalanced exosomal data via Exo-LCClassifier.Frontiers in genetics · 2025Article
- Artificial intelligence-driven analysis of antibody and nucleic acid biomarkers for enhanced disease diagnostics.Frontiers in immunology · 2025Article
- Cancer genetics and deep learning applications for diagnosis, prognosis, and categorization.Journal of biological methods · 2024Review
- Research in the application of artificial intelligence to lung cancer diagnosis.Frontiers in medicine · 2024Review
- Diagnostic Accuracy of Machine Learning AI Architectures in Detection and Classification of Lung Cancer: A Systematic Review.Diagnostics (Basel, Switzerland) · 2023Review
- Machine Learning Methods for Cancer Classification Using Gene Expression Data: A Review.Bioengineering (Basel, Switzerland) · 2023Review
- Emerging Applications of Deep Learning in Bone Tumors: Current Advances and Challenges.Frontiers in oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLung cancer is one of the cancers with the highest mortality rate in China. With the rapid development of high-throughput sequencing technology and the research and application of deep learning methods in recent years, deep neural networks based on gene expression have become a hot research direction in lung cancer diagnosis in recent years, which provide an effective way of early diagnosis for lung cancer. Thus, building a deep neural network model is of great significance for the early diagnosis of lung cancer. However, the main challenges in mining gene expression datasets are the curse of dimensionality and imbalanced data. The existing methods proposed by some researchers can't address the problems of high-dimensionality and imbalanced data, because of the overwhelming number of variables measured (genes) versus the small number of samples, which result in poor performance in early diagnosis for lung cancer.
methodGiven the disadvantages of gene expression data sets with small datasets, high-dimensionality and imbalanced data, this paper proposes a gene selection method based on KL divergence, which selects some genes with higher KL divergence as model features. Then build a deep neural network model using Focal Loss as loss function, at the same time, we use k-fold cross validation method to verify and select the best model, we set the value of k is five in this paper.
resultThe deep learning model method based on KL divergence gene selection proposed in this paper has an AUC of 0.99 on the validation set. The generalization performance of model is high.
conclusionThe deep neural network model based on KL divergence gene selection proposed in this paper is proved to be an accurate and effective method for lung cancer prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.